Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Chronic Heart Failure

  Free Subscription


4 Am J Cardiol
4 Circ Heart Fail
1 Circ Res
1 Circulation
1 Clin Cardiol
4 Eur Heart J
9 Eur J Heart Fail
1 J Am Coll Cardiol
7 J Card Fail
2 J Cardiovasc Pharmacol
1 J Mol Cell Cardiol
3 Lancet
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Cardiol

  1. ILKHANOFF L, Atwater B, Barac A
    Atrial Fibrillation Amplifies Heart Failure Risk in Anthracycline Treated Cancer Patients: Stacking Risk Factors in the Vulnerable.
    Am J Cardiol. 2024 Mar 2:S0002-9149(24)00120.

  2. RUDZINSKI PN, Henzel J, Witkowski A, Dabrowski M, et al
    Transcatheter Intervention for Inoperable Tricuspid Surgical Prosthesis Dysfunction: Minimally Invasive Approach to Mitigate Heart Failure.
    Am J Cardiol. 2024 Mar 1:S0002-9149(24)00154.

  3. SANTANA EJ, Christle JW, Cauwenberghs N, Peterman JE, et al
    Improving Reporting of Exercise Capacity Across Age Ranges Using Novel Workload Reference Equations.
    Am J Cardiol. 2024;215:32-41.
    PubMed         Abstract available

  4. PASSAFARO F, Rapacciuolo A, Ruocco A, Ammirati G, et al
    COMPArison of Multi-Point Pacing and ConvenTional CRT Through Non-invasive Hemodynamics Measurement: Short and Long Term Results of the COMPACT-MPP Study.
    Am J Cardiol. 2024 Jan 16:S0002-9149(24)00034.
    PubMed         Abstract available

    Circ Heart Fail

  5. LU DY, Kanduri J, Yeo I, Goyal P, et al
    Impact of Advanced Therapy Centers on Characteristics and Outcomes of Heart Failure Admissions.
    Circ Heart Fail. 2024 Mar 8:e011115. doi: 10.1161/CIRCHEARTFAILURE.123.011115.
    PubMed         Abstract available

  6. BEUSSINK-NELSON L, Freed BH, Chirinos JA, Brubaker PH, et al
    Multi-Ethnic Study of Atherosclerosis Early Heart Failure Study: Rationale, Design, and Baseline Characteristics.
    Circ Heart Fail. 2024 Mar 8:e010289. doi: 10.1161/CIRCHEARTFAILURE.122.010289.
    PubMed         Abstract available

  7. REZA N
    High Intensity Care vs. GDMT Titration: Which Rapidly Improves Health Status in Patients With Heart Failure?
    Circ Heart Fail. 2024 Mar 6. doi: 10.1161/CIRCHEARTFAILURE.124.011627.

  8. KAPELIOS CJ, Greene SJ, Mentz RJ, Ikeaba U, et al
    Torsemide Versus Furosemide After Discharge in Patients Hospitalized With Heart Failure Across the Spectrum of Ejection Fraction: Findings From TRANSFORM-HF.
    Circ Heart Fail. 2024 Mar 4:e011246. doi: 10.1161/CIRCHEARTFAILURE.123.011246.
    PubMed         Abstract available

    Circ Res

  9. CURAJ A, Vanholder R, Loscalzo J, Quach K, et al
    Cardiovascular Consequences of Uremic Metabolites: an Overview of the Involved Signaling Pathways.
    Circ Res. 2024;134:592-613.
    PubMed         Abstract available


  10. OSTERGAARD L, Olesen JB, Petersen JK, Nielsen LS, et al
    Arterial Thromboembolism in Patients With Atrial Fibrillation and CHA(2)DS(2)-VASc 1: A Nationwide Study.
    Circulation. 2023 Dec 28. doi: 10.1161/CIRCULATIONAHA.123.066477.
    PubMed         Abstract available

    Clin Cardiol

  11. KIM JH, Yoon YC, Kim YH, Park JI, et al
    Cardiovascular outcomes between dapagliflozin versus empagliflozin in patients with diabetes mellitus.
    Clin Cardiol. 2024;47:e24248.
    PubMed         Abstract available

    Eur Heart J

  12. Correction to: Conventional heart failure therapy in cardiac ATTR amyloidosis.
    Eur Heart J. 2024 Mar 1:ehae140. doi: 10.1093.

  13. SAYOUR NV, Paal AM, Ameri P, Meijers WC, et al
    Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidence.
    Eur Heart J. 2024 Mar 5:ehae105. doi: 10.1093.
    PubMed         Abstract available

  14. CHAIX MA, Dore A, Mondesert B, Mongeon FP, et al
    Angiotensin receptor-neprilysin inhibitor vs. placebo in congenital systemic right ventricular heart failure: the PARACYS-RV trial.
    Eur Heart J. 2024 Mar 6:ehad890. doi: 10.1093.

  15. CLELAND JGF, Kalra PA, Pellicori P, Graham FJ, et al
    Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trial.
    Eur Heart J. 2024 Mar 6:ehae086. doi: 10.1093.
    PubMed         Abstract available

    Eur J Heart Fail

  16. CHUNAWALA ZS, Keshvani N, Segar MW, Patel KV, et al
    Association of diabetes-specific heart failure risk score with presence of subclinical cardiomyopathy among individuals with diabetes: A prospective study.
    Eur J Heart Fail. 2024 Mar 4. doi: 10.1002/ejhf.3176.

  17. RICHARDS AM, Wang P, Wong LL
    'Micro'-managing heart failure: Restoring that which was lost in translation.
    Eur J Heart Fail. 2024 Mar 4. doi: 10.1002/ejhf.3188.

  18. FERREIRA JP, Packer M, Sattar N, Butler J, et al
    Carbohydrate antigen 125 concentrations across the ejection fraction spectrum in chronic heart failure: The EMPEROR programme.
    Eur J Heart Fail. 2024 Mar 4. doi: 10.1002/ejhf.3166.
    PubMed         Abstract available

  19. FERREIRA JP, Zannad F, Packer M, Filippatos G, et al
    Empagliflozin and risk of lower respiratory tract infection in heart failure with mildly reduced and preserved ejection fraction: An EMPEROR-Preserved analysis.
    Eur J Heart Fail. 2024 Mar 4. doi: 10.1002/ejhf.3180.
    PubMed         Abstract available

  20. TUBBEN A, Tingen HSA, Prakken NHJ, van Empel VPM, et al
    Prevalence of wild-type transthyretin amyloidosis in a prospective heart failure cohort with preserved and mildly reduced ejection fraction: Results of the Amylo-VIP-HF study.
    Eur J Heart Fail. 2024 Mar 4. doi: 10.1002/ejhf.3186.

  21. BUTLER J, Mentz RJ, Hernandez AF
    Iron replacement therapy in heart failure: Contextualizing the results of the HEART-FID trial.
    Eur J Heart Fail. 2024 Mar 4. doi: 10.1002/ejhf.3193.

  22. PAGNESI M, Vilamajo OAG, Meirino A, Dumont CA, et al
    Blood pressure and intensive treatment up-titration after acute heart failure hospitalization: Insights from the STRONG-HF trial.
    Eur J Heart Fail. 2024 Mar 5. doi: 10.1002/ejhf.3174.
    PubMed         Abstract available

  23. ROUBILLE F, Mercier G, Lancman G, Pasche H, et al
    Weight telemonitoring of heart failure versus standard of care in a real-world setting: Results on mortality and hospitalizations in a 6-month nationwide matched cohort study.
    Eur J Heart Fail. 2024 Mar 7. doi: 10.1002/ejhf.3191.
    PubMed         Abstract available

  24. EZEKOWITZ J, Alemayehu W, Edelmann F, Ponikowski P, et al
    Diuretic use and outcomes in patients with heart failure with reduced ejection fraction: Insights from the VICTORIA trial.
    Eur J Heart Fail. 2024 Mar 7. doi: 10.1002/ejhf.3179.
    PubMed         Abstract available

    J Am Coll Cardiol

  25. FUSTER V
    Editor-in-Chief's Top Picks From 2023.
    J Am Coll Cardiol. 2024;83:961-1026.
    PubMed         Abstract available

    J Card Fail

  26. WALTERS GW, Yeo JL, Bilak JM, Pepper C, et al
    The Effectiveness of Lifestyle Interventions in Heart Failure with Preserved Ejection Fraction: A Systematic review and Network Meta-Analysis.
    J Card Fail. 2024 Feb 28:S1071-9164(24)00046.
    PubMed         Abstract available

    Changing the Narrative About a Career in Heart Failure.
    J Card Fail. 2024 Mar 1:S1071-9164(24)00045.

  28. MULLENS W, Martens P
    Contemporary Diuretic Therapies for Acute Heart Failure, time for a Desalination-Guided Approach?
    J Card Fail. 2024 Feb 22:S1071-9164(24)00043.

  29. BORLAUG BA, Kindel TL
    JCF Ignite: Obesity and Heart Failure: A New Era Begins.
    J Card Fail. 2024 Mar 2:S1071-9164(24)00068.

  30. PACKER M
    The Ideal Heart Rate for Heart Failure and Ejection Fraction > 40%: Both Myth and Magic?
    J Card Fail. 2024 Mar 1:S1071-9164(24)00069.

  31. AURORA L, Grafton G, Cowger J
    Going with the Flow: Device therapy for Heart Failure Complicated by Cardiorenal Syndrome.
    J Card Fail. 2024 Feb 29:S1071-9164(24)00066.

  32. BUENDIA R, Karpefors M, Folkvaljon F, Hunter R, et al
    Wearable Sensors to Monitor Physical Activity in Heart Failure Clinical Trials: State-of-the-Art Review.
    J Card Fail. 2024 Mar 5:S1071-9164(24)00072.
    PubMed         Abstract available

    J Cardiovasc Pharmacol

  33. SUN Q, Cui W, Zhang X, Tian Y, et al
    A Systematic Review and Meta-analysis of Renin-angiotensin Inhibitors and Angiotensin Receptor Neprilysin Inhibitors in Preventing Recurrence after Atrial Fibrillation Ablation.
    J Cardiovasc Pharmacol. 2023 Nov 22. doi: 10.1097/FJC.0000000000001517.
    PubMed         Abstract available

  34. ZOHORI BAHRAMI HS, Hasselbalch RB, Soholm H, Thomsen JH, et al
    First-in-man trial of beta3-adrenoceptor agonist treatment in chronic heart failure - impact on diastolic function.
    J Cardiovasc Pharmacol. 2024 Mar 5. doi: 10.1097/FJC.0000000000001545.
    PubMed         Abstract available

    J Mol Cell Cardiol

  35. NGUYEN T, Rosa-Garrido M, Sadek H, Garry DJ, et al
    Promoting cardiomyocyte proliferation for myocardial regeneration in large mammals.
    J Mol Cell Cardiol. 2024;188:52-60.
    PubMed         Abstract available


  36. KIKOINE J, Kilani N, Pitta-Gros B, Yerly P, et al
    Remote haemodynamic monitoring in patients with heart failure.
    Lancet. 2024;403:808.

  37. BRUGTS JJ, Aydin D, Clephas PRD, de Boer RA, et al
    Remote haemodynamic monitoring in patients with heart failure - Authors' reply.
    Lancet. 2024;403:808-809.

  38. KOMAMURA K, Iwase M
    Remote haemodynamic monitoring in patients with heart failure.
    Lancet. 2024;403:807-808.

    PLoS One

  39. MAEDA M, Humber D, Hida E, Ohtani T, et al
    Lower doses of carvedilol in Japanese heart failure patients with reduced ejection fraction could show the potential to be non-inferior to higher doses in US patients: An international collaborative observational study.
    PLoS One. 2024;19:e0299510.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.